≥10 mm on ultrasound and capsular retraction or vascular invasion, further workup with CT or MRI would be required ( Figure 1 ). In the United States, Dr. Covey noted that CT and MRI seem to be used more often than ultrasound for detecting HCC. In
Search Results
Dong-Xu Qiu, Jian Li, Jin-Wei Zhang, Min-Feng Chen, Xiao-Mei Gao, Yong-Xiang Tang, Ye Zhang, Xiao-Ping Yi, Hong-ling Yin, Yu Gan, Gui-Lin Wang, Xiong-Bing Zu, Shuo Hu, and Yi Cai
INTRODUCTION AND OBJECTIVE : Growing evidence proved the efficacy of multiparametric MRI (mpMRI) and prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT)-guided targeted biopsy (TB) in prostate
days 16 through 20. TAS-102 will be self-administered (in tablet form) by the study participant and documented in a provided drug diary. Response assessment via CT imaging (or MRI) will be obtained every 8 weeks. Treatment will continue until disease
Steven J. Schuetz, Claudia B. Soliz P., Maribel Marmol C., Marco A. Vasquez V., and Robert W. Carlson
basic, core and enhanced resource levels will utilize rigid proctoscopy and pelvic CT due to inaccessibility of MRI and endorectal ultrasound, with abdominal ultrasound and chest radiographs to evaluate metastatic disease at basic and core levels
Anastasia Tararykova, Alexander Fedenko, and Elmar Musaev
observed 40 advanced or unresectable GCT cases from 2005 till 2020 in N.N. Blokhin NMRCO. Patients underwent CT/MRI every 3 months during the first three years and then once every six months. Patient received subcutaneous denosumab (Db) 120 mg every 4 weeks
6 and days 16 through 20. TAS-102 will be self-administered (in tablet form) by the study participant and documented in a provided drug diary. Response assessment via CT imaging (or MRI) will be obtained every 8 weeks. Treatment will continue until
Peter R. Carroll, J. Kellogg Parsons, Gerald Andriole, Robert R. Bahnson, Daniel A. Barocas, Erik P. Castle, William J. Catalona, Douglas M. Dahl, John W. Davis, Jonathan I. Epstein, Ruth B. Etzioni, Thomas Farrington, George P. Hemstreet III, Mark H. Kawachi, Paul H. Lange, Kevin R. Loughlin, William Lowrance, Paul Maroni, James Mohler, Todd M. Morgan, Robert B. Nadler, Michael Poch, Chuck Scales, Terrence M. Shaneyfelt, Marc C. Smaldone, Geoffrey Sonn, Preston Sprenke, Andrew J. Vickers, Robert Wake, Dorothy A. Shead, and Deborah Freedman-Cass
the American College of Radiology gives recommendations for high-quality MRI in prostate cancer care, including recommendations related to the use of MRI to direct targeted biopsies. 106 In addition, the European Society of Urogenital Radiology
Kaylene Ready and Banu Arun
, proven screening and risk reduction modalities are available. For example, a woman carrying a BRCA1 or BRCA2 mutation can be offered the following risk management options: semiannual breast cancer screening using both mammogram and breast MRI 3
Al B. Benson III, Alan P. Venook, Mahmoud M. Al-Hawary, Lynette Cederquist, Yi-Jen Chen, Kristen K. Ciombor, Stacey Cohen, Harry S. Cooper, Dustin Deming, Paul F. Engstrom, Jean L. Grem, Axel Grothey, Howard S. Hochster, Sarah Hoffe, Steven Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey Meyerhardt, Mary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky-Himelfarb, Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Lisa Gurski, and Deborah A. Freedman-Cass
rectum, which lies below a virtual line from the sacral promontory to the upper edge of the symphysis as determined by MRI (see Figure 1, online, in these guidelines, at NCCN.org ). The rectum ends at the superior border of the functional anal canal
Rahel Demisse, Neha Damle, Edward Kim, Jun Gong, Marwan Fakih, Cathy Eng, Leslie Oesterich, Madison McKenny, Jingran Ji, James Liu, Ryan Louie, Kit Tam, Sepideh Gholami, Wissam Halabi, Arta Monjazeb, Farshid Dayyani, and May Cho
expression in both tumors. An MRI of the pelvis showed a synchronous T3cN1 tumor in the low rectum and a T1/T2N0 tumor in the midrectum. The mesorectal fascia was threatened, and an extramesorectal/left internal iliac lymph node was suspicious for tumor
